NUVATION BIO INC's ticker is NUVB and the CUSIP is 67080N101. A total of 126 filers reported holding NUVATION BIO INC in Q3 2023. The put-call ratio across all filers is 0.00 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4,061,552 | -25.6% | 3,031,009 | 0.0% | 0.19% | -7.7% |
| Q2 2023 | $5,455,816 | +8.4% | 3,031,009 | 0.0% | 0.21% | -4.1% |
| Q1 2023 | $5,031,475 | -13.5% | 3,031,009 | 0.0% | 0.22% | -8.4% |
| Q4 2022 | $5,819,537 | -14.3% | 3,031,009 | 0.0% | 0.24% | -9.5% |
| Q3 2022 | $6,789,000 | -39.6% | 3,031,009 | -12.7% | 0.26% | -38.7% |
| Q2 2022 | $11,248,000 | -38.4% | 3,471,709 | 0.0% | 0.43% | -24.7% |
| Q1 2022 | $18,261,000 | -41.5% | 3,471,709 | -5.4% | 0.57% | -19.6% |
| Q4 2021 | $31,204,000 | -30.9% | 3,671,009 | -19.2% | 0.71% | -9.9% |
| Q3 2021 | $45,138,000 | +6.8% | 4,541,009 | 0.0% | 0.79% | +25.7% |
| Q2 2021 | $42,277,000 | -10.9% | 4,541,009 | 0.0% | 0.63% | -6.3% |
| Q1 2021 | $47,454,000 | – | 4,541,009 | – | 0.67% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Omega Fund Management, LLC | 22,957,340 | $120,756,000 | 24.71% |
| Aisling Capital Management LP | 2,541,009 | $13,366,000 | 7.21% |
| EDBI Pte Ltd | 1,270,504 | $6,683,000 | 4.45% |
| Ally Bridge Group (NY) LLC | 1,137,152 | $5,981,000 | 4.43% |
| EcoR1 Capital, LLC | 13,896,543 | $73,096,000 | 2.29% |
| Boxer Capital, LLC | 4,341,009 | $22,834,000 | 1.17% |
| Baupost Group | 10,443,494 | $54,933,000 | 0.59% |
| Redmile Group, LLC | 3,471,709 | $18,261,000 | 0.57% |
| Avidity Partners Management LP | 4,855,006 | $25,537,000 | 0.53% |
| Abrams Capital Management | 3,811,513 | $20,049,000 | 0.47% |